NCT07182201

Brief Summary

The pain and abnormal gait postures observed in CPF patients may be associated with impaired foot function. However, few studies have examined the dorsiflexion function of the big toe in CPF patients, and the effectiveness of foot core control training in alleviating pain and improving gait remains unclear. Restricted movement of the metatarsophalangeal joint (MTPJ1) may severely compromise foot function, leading to gait pattern alterations and subsequent instability. To address this, our study aims to improve symptoms, functional outcomes, and gait through foot core control training interventions. We recorded kinematic parameters and biomechanical data during the foot's plantar phase at toe-off before and after functional training for CPF patients. Comparative analysis between intervention groups revealed whether foot core control training can effectively enhance big toe dorsiflexion function and gait biomechanics in CPF patients. This research clarifies the therapeutic efficacy of foot core control training for CPF patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 19, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

September 22, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 19, 2025

Status Verified

September 1, 2025

Enrollment Period

3 months

First QC Date

September 11, 2025

Last Update Submit

September 11, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Vicon 3D gait test

    subjects wore athletic shorts, fully exposing the waist and the area below the mid-thigh. After reflective markers were attached, subjects familiarized themselves with the movement collection requirements and procedures according to the testing protocol. They stood in the center of the testing room with their feet shoulder-width apart and upper limbs resting naturally at their sides, maintaining the subtalar joint in a neutral position. A static test was conducted to collect reference data for defining the coordinate systems of the bone segments. Subsequently, participants performed walking, jogging, side-cutting, jumping, and single-leg balance tasks at a self-selected comfortable pace. Sufficient rest was provided between trials to prevent fatigue. Five valid trials were collected for each movement, and the average of three trials was used for analysis.

    30 minutes

  • Evaluation of dorsiflexion function of big toe

    Goniometric measurement: The subject removes footwear and stands weight-bearing on a yoga mat, actively dorsiflexing the big toe. The tester measures the dorsiflexion angle of the big toe using a goniometer. The goniometer's axis is aligned with the big toe's MTPJ1, with the fixed arm parallel to the first metatarsal and the movable arm parallel to the first proximal phalanx. The movable arm is adjusted according to the subject's dorsiflexion angle, with measurements recorded. Three trials are performed and averaged. Vicon measurement: The subject's MTPJ1 angle during walking is recorded using Vicon technology.

    30 minutes

Secondary Outcomes (2)

  • Visual analog scale (VAS)

    5minutes

  • ankle and hindfoot function scale (AOFAS)

    5 minutes

Study Arms (2)

Foot core control training combined + regular CPF training

EXPERIMENTAL
Behavioral: Foot core control trainingBehavioral: CPF Conventional training

regular CPF training

ACTIVE COMPARATOR
Behavioral: CPF Conventional training

Interventions

(1) Toe Yoga : When MTPJ1 actively dorsiflexes, the other four toes remain in contact with the ground. The subject lifts the big toe while the remaining four toes stay on the ground; conversely, when the big toe contacts the ground, the other four toes lift upward, alternating this pattern. (2)Doming: While keeping MTPJ1 in contact with the ground, elevate the foot arch. This exercise strengthens intrinsic foot muscle strength, helping stabilize the arch and first metatarsal. The subject tightens the toes, bringing the forefoot toward the heel to form and enhance the arch. Maintain all toes firmly planted on the ground, ensuring no ankle inversion, no forced flexion or extension of toes, and hold at maximum position. Perform training seated to avoid compensatory movements by external muscles during exercise. (3) Toe Abduction Exercises(4)Dynamic Exercise Progression

Foot core control training combined + regular CPF training

The key points of the exercise are as follows: (1) Fascia ball release of plantar fascia (2) Plantar fascia stretching (3) Gastrocnemius muscle stretching (4) Toe grab towel

Foot core control training combined + regular CPF trainingregular CPF training

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • (1) Ultrasound findings indicating plantar fascia thickness\>4 mm or 20% thickening compared to the contralateral side; (2) Age 25-45 years; (3) Ankle dorsiflexion range \<65° in weight-bearing standing position; (4) Persistent heel pain lasting ≥3 months but ≤1 year; (5) No prior treatment within 1 month prior to hospital admission; (6) Subjects without prior CPF surgical intervention.

You may not qualify if:

  • (1) Concurrent presence of severe malignant diseases; (2) Abnormal conditions such as skin ulcers or infections on the sole; (3) Concurrent neurological or immunological disorders; (4) Concurrent heel deformity or fracture; (5) Secondary CPF caused by rheumatoid arthritis, ankylosing spondylitis, or other conditions; (6) Concurrent cognitive impairment, mental abnormalities, or difficulty completing relevant assessment scales.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Fasciitis, Plantar

Condition Hierarchy (Ancestors)

FasciitisMusculoskeletal DiseasesFoot Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2025

First Posted

September 19, 2025

Study Start

September 22, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

September 19, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share